front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 | 27|28 |29 |30 |31 |32 |33 |34 |35 |36 |37 ||38 |39 |40 |41 |42 |43 |44 |45 |46 |47 |48 |49 |50 |51 |52 |53 |54 |review |
MODY1
is caused by mutations in the HNF4A gene (OMIM 600281), which
encodes the hepatocyte nuclear factor 4-alpha gene on chromosome
20q12-q13.1. It is also known as
TCF14 (transcription factor 14). HNF4A is a transcription factor
that is expressed in the liver, kidney, intestine and pancreatic islet
cells. It controls expression
of genes involved in glucose, cholesterol and fatty acid metabolism,
including glucose transporter 2, aldolase B, glyceraldehyde-3-phosphate
dehydrogenase and pyruvate kinase.
It also regulates transcription of the transcription factor
HNF1A (OMIM
142410), which is the
gene that causes MODY3.
HNF4A may also play
a role in NIDDM, particularly in individuals with a young age at onset.
Approximately 12 missense and nonsense mutations, as well as a
splicing defect, in HNF4A have been
identified in families with
MODY1. All appear to reduce
gene expression. MODY1 accounts for
about
5% of all MODY cases.
|